Drug Database
Back to search

Canada· CA-DIN-02410826

BERIPLEX P/N 1000

A coagulation factor ix, ii, vii and x in combination product containing coagulation factor ix (human) + coagulation factor ii (human) + coagulation factor x (human) + coagulation factor vii (human), registered in Canada by CSL BEHRING CANADA INC. The same ATC class is registered in 11 of our 19 countries.

ATC B02BD01

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedBERIPLEX P/N 1000ATCB02BD01REGISTER NO.CA-DIN-02410826PACKS LISTED0CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about coagulation factor ix (human) + coagulation factor ii (human) + coagulation factor x (human) + coagulation factor vii (human)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Coagulation factor ix, ii, vii and x in combination is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BD01 (coagulation factor ix, ii, vii and x in combination), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 7 of them publish a price we can compare per daily dose
Search coagulation factor ix, ii, vii and x in combination products by name

Coagulation factor ix, ii, vii and x in combination · ATC B02BD01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
COAGULATION FACTOR IX (HUMAN) + COAGULATION FACTOR II (HUMAN) + COAGULATION FACTOR X (HUMAN) + COAGULATION FACTOR VII (HUMAN)
Manufacturer
CSL BEHRING CANADA INC
Country
Canada (CA)
ATC code
B02BD01
ATC class
Coagulation factor IX, II, VII and X in combination
Defined daily dose
1.6 TSD, E
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for coagulation factor ix, ii, vii and x in combination.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check coagulation factor ix, ii, vii and x in combination against other medicinesHow interaction checks work

Coagulation factor ix, ii, vii and x in combination · interactions on record

3 records

  • 2 severe
  • 1 moderate

Most severe, free to view

  • CarfilzomibL01XG02severe
  • CarfilzomibL01XX45severe
  • PegvaliaseA16AB19moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under B02BD01

Coagulation factor ix, ii, vii and x in combination, as other registers publish it.

All coagulation factor ix, ii, vii and x in combination products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b4638472-60c0-4de5-904e-8d228c0528e9
GET /v1/drugs/b4638472-60c0-4de5-904e-8d228c0528e9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02410826",
  "form": "POWDER FOR SOLUTION",
  "class": "Human",
  "routes": [
    "INTRAVENOUS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "B02BD01",
  "schedule": [
    "Schedule D"
  ],
  "drug_code": "89540",
  "strengths": [
    "1240 UNIT",
    "1600 UNIT",
    "2040 UNIT",
    "1000 UNIT",
    "1640 UNIT",
    "1360 UNIT"
  ],
  "ahfs_class": null,
  "substances": [
    "COAGULATION FACTOR IX (HUMAN)",
    "COAGULATION FACTOR II (HUMAN)",
    "COAGULATION FACTOR X (HUMAN)",
    "COAGULATION FACTOR VII (HUMAN)",
    "PROTEIN C",
    "PROTEIN S"
  ],
  "product_categorization": null
}
API referenceMCP serverPlans

See everything about coagulation factor ix, ii, vii and x in combination.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console